Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$79.4 - $116.36 $1.99 Million - $2.91 Million
-25,000 Reduced 29.41%
60,000 $4.79 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $4.75 Million - $6.04 Million
-55,000 Reduced 39.29%
85,000 $8.94 Million
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $13.4 Million - $16.3 Million
-136,000 Reduced 49.28%
140,000 $15.1 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $827,190 - $993,330
-9,000 Reduced 3.16%
276,000 $30.2 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $3.02 Million - $3.36 Million
35,000 Added 14.0%
285,000 $26.7 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $3.59 Million - $4.77 Million
50,000 Added 25.0%
250,000 $23 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $4.36 Million - $5.49 Million
65,000 Added 48.15%
200,000 $14.6 Million
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $7.46 Million - $10.8 Million
135,000 New
135,000 $10.5 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.